Company Profile
Paragon 28 Stock Price, News & Catalysts
- Ticker:
- FNA
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for FNA.
Company overview
Business overview
Paragon 28 is a foot-and-ankle orthopedic device company focused on specialized surgical implants and instrumentation. The company’s strategy centers on procedure growth and surgeon adoption.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Paragon 28 sits in procedure-driven medtech.
Business Model Characteristics
Its economics depend on surgical adoption, product launches, and the growth of the foot-and-ankle franchise.
Position Within the Biotechnology Landscape
Paragon 28 is a niche orthopedic device company whose valuation is driven more by procedure execution than by biotech-style catalysts.
Future catalysts
- Paragon 28's catalysts are foot-and-ankle implant adoption and continued surgeon penetration in a niche orthopedic market. The company needs more repeatable procedural share to keep re-rating.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Paragon 28 do?
Paragon 28 is a foot-and-ankle orthopedic device company focused on specialized surgical implants and instrumentation. The company’s strategy centers on procedure growth and surgeon adoption.
On which exchange is FNA stock listed?
Paragon 28 (FNA) is associated with NYSE, United States, MedTech.
What is Paragon?
Paragon 28's catalysts are foot-and-ankle implant adoption and continued surgeon penetration in a niche orthopedic market.
Which conditions is Paragon 28 targeting with Paragon?
Paragon 28's catalysts are foot-and-ankle implant adoption and continued surgeon penetration in a niche orthopedic market.
How does Paragon 28 describe recent progress with Paragon?
Paragon 28's catalysts are foot-and-ankle implant adoption and continued surgeon penetration in a niche orthopedic market.
What future catalysts are investors watching for Paragon 28?
Paragon 28's catalysts are foot-and-ankle implant adoption and continued surgeon penetration in a niche orthopedic market. The company needs more repeatable procedural share to keep re-rating.